Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

ClinicalTrials.gov ID: NCT06417775

Public ClinicalTrials.gov record NCT06417775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Ubrogepant for the Preventive Treatment of Menstrual Migraine With an Open-Label Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. Menstrual migraine (MM) is defined as migraine attacks that occur within the perimenstrual period (PMP) in at least 2 out of 3 menstrual cycles. The PMP is from 2 days before the onset of menstrual bleeding to 2 days after. This study will assess how safe and effective ubrogepant is in treating menstrual migraine. Adverse Events and change in disease activity will be assessed. Ubrogepant is an investigational drug being developed for short-term prevention of menstrual migraine. Participants will be randomly assigned to one of the 2 groups to receive either ubrogepant or placebo. Around 496 adult female participants with menstrual migraine will be enrolled in approximately 100 sites in the United States and Puerto Rico. Participants will receive oral ubrogepant tablets once daily for 7 consecutive days starting 3 days prior to estimated onset of menses per cycle for 3 PMPs during double-blind period (16 weeks). Eligible participants may continue to receive oral ubrogepant tablets once daily for 7 consecutive days per cycle starting 3 days prior to estimated onset of menses during open-label extension period (52 weeks). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will collect data daily in electronic diaries and attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Study identification

NCT ID
NCT06417775
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
496 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 10, 2024 (Actual)
Primary completion
Nov 2027 (Estimated)
Completion
Nov 2027 (Estimated)
Last update posted
Aug 14, 2026

2024 – 2027

United States locations

U.S. sites
103
U.S. states
39
U.S. cities
95
Facility City State ZIP Site status
Central Research Associates /ID# 260161 Birmingham Alabama 35205 —
Rehabilitation and Neurological Services /ID# 275593 Huntsville Alabama 35805 —
MD First Research - Chandler /ID# 262564 Chandler Arizona 85286 —
Gilbert Neurology /ID# 260179 Gilbert Arizona 85297 —
Foothills Research Center/CCT Research /ID# 260180 Phoenix Arizona 85044 —
Trialmed-Synexus Clinical Research US, Inc. - Tucson /ID# 258309 Tucson Arizona 85741 —
Preferred Research Partners /ID# 262786 Little Rock Arkansas 72211 —
Preferred Research Partners /ID# 273128 Little Rock Arkansas 72211 —
Hope Clinical Research /ID# 257867 Canoga Park California 91303 —
Axiom Research /ID# 257833 Colton California 92324 —
Neuro Pain Research Center /ID# 257155 Fresno California 93710 —
Axiom Research, LLC-Los Angeles /ID# 264085 Glendale California 91206 —
Sun Valley Research Center /ID# 257152 Imperial California 92251-9401 —
Axiom Research - Irvine /ID# 264083 Irvine California 92604 —
CenExel Collaborative Neuroscience Research /ID# 257828 Los Alamitos California 90720 —
BNL Health - Los Angeles Headache Center /ID# 257237 Los Angeles California 90067-2001 —
M3 Wake Research - Newport Beach /ID# 257158 Newport Beach California 92660 —
Artemis Institute for Clinical Research - San Diego /ID# 257134 San Diego California 92103-2204 —
M3 Wake Research - Convoy /ID# 257897 San Diego California 92111 —
Optimus Medical /ID# 257856 San Francisco California 94102 —
New England Institute for Clinical Research /ID# 264019 Stamford Connecticut 06905 —
Neurology Offices of South Florida, PLLC /ID# 257161 Boca Raton Florida 33428-2231 —
Accel Research Sites Network - DeLand Clinical Research Unit /ID# 257403 DeLand Florida 32720 —
Accel Research Sites - Lakeland Clinical Research Unit /ID# 257874 Lakeland Florida 33803 —
Well Pharma Medical Research /ID# 257199 Miami Florida 33143 —
Indago Research and Health Center /ID# 277943 Miami Lakes Florida 33016 —
Sensible Healthcare /ID# 257198 Ocoee Florida 34761 —
Clinical Neuroscience Solutions, Inc /ID# 257190 Orlando Florida 32801-2986 —
Conquest Research /ID# 258314 Winter Park Florida 32789 —
NeuroTrials Research /ID# 274507 Atlanta Georgia 30328 —
Clinical Research Atlanta - Headlands LLC /ID# 260181 Stockbridge Georgia 30281-9054 —
Hawaii Pacific Neuroscience /ID# 274469 Honolulu Hawaii 96817 —
Velocity Clinical Research - Boise /ID# 257135 Meridian Idaho 83642 —
Healthcare Research Network /ID# 257868 Tinley Park Illinois 60477 —
Deaconess Midtown Hospital /ID# 257400 Evansville Indiana 47710 —
Accellacare - McFarland Clinic /ID# 257834 Ames Iowa 50010 —
Alliance for Multispecialty Research LLC /ID# 257839 Newton Kansas 67114 —
Collective Medical Research /ID# 257131 Overland Park Kansas 66210 —
Alliance For Multispeciality Research - Wichita East /ID# 257148 Wichita Kansas 67207 —
Tandem Clinical Research - Marrero - Barataria Boulevard /ID# 260146 Marrero Louisiana 70072 —
IMA Clinical Research Monroe - Wood /ID# 259362 Monroe Louisiana 71201 —
Headlands PharmaSite /ID# 257208 Baltimore Maryland 21208 —
Boston Clinical Trials /ID# 257132 Boston Massachusetts 02131-2515 —
BTC of New Bedford /ID# 257128 New Bedford Massachusetts 02740 —
MedVadis Research /ID# 257156 Waltham Massachusetts 02451 —
Michigan Headache & Neurological Institute (MHNI) /ID# 257179 Ann Arbor Michigan 48104-5131 —
Memorial Healthcare Institute For Neuroscience /ID# 274663 Owosso Michigan 48867 —
Proven Endpoints LLC /ID# 273796 Ridgeland Mississippi 39157 —
HealthCare Research Network - Hazelwood /ID# 257402 Hazelwood Missouri 63042 —
Clinvest Research LLC /ID# 257215 Springfield Missouri 65807 —
Methodist Physicians Clinic/CCT Research /ID# 260167 Fremont Nebraska 68025 —
Cognitive Clinical Trials (CCT) - Papillion /ID# 260174 Papillion Nebraska 68046-4131 —
IMA Clinical Research Las Vegas /ID# 258679 Las Vegas Nevada 89102-1955 —
M3 Wake Research-Las Vegas Rainbow /ID# 257895 Las Vegas Nevada 89118-2557 —
Bio Behavioral Health, Inc /ID# 257140 Toms River New Jersey 08755-6434 —
IMA Clinical Research Warren /ID# 263641 Warren Township New Jersey 07059 —
Albuquerque Clinical Trials, Inc. /ID# 257212 Albuquerque New Mexico 87102 —
Dent Neurologic Institute - Amherst /ID# 257219 Amherst New York 14226 —
IMA Clinical Research Westchester /ID# 259157 Hartsdale New York 10530 —
Fieve Clinical Research, Inc. /ID# 257177 New York New York 10017-1921 —
Rochester Clinical Research /ID# 257193 New York New York 14609 —
True North Neurology /ID# 274672 Port Jefferson Station New York 11776 —
Upstate Clinical Research Associates /ID# 257163 Williamsville New York 14221-6046 —
Headache Wellness Center /ID# 257136 Greensboro North Carolina 27405 —
Accellacare - South Hawthorne Road - Winston-Salem /ID# 257731 Winston-Salem North Carolina 27103 —
Accellacare - South Hawthorne Road - Winston-Salem /ID# 257850 Winston-Salem North Carolina 27103 —
Lillestol Research, LLC /ID# 257896 Fargo North Dakota 58104 —
CTI Clinical Research Center /ID# 257162 Cincinnati Ohio 45212-3784 —
C7 Research /ID# 272815 Cleveland Ohio 44109 —
Centricity Research Columbus /ID# 257221 Columbus Ohio 43213 —
Wright State Physicians Health Center /ID# 274708 Fairborn Ohio 45324 —
Lynn Institute of Oklahoma City /ID# 257857 Oklahoma City Oklahoma 73112 —
Central States Research /ID# 277867 Tulsa Oklahoma 74136 —
Summit Research Network - Portland - Northwest Vaughn Street /ID# 257139 Portland Oregon 97210 —
Abington Neurological Associates - Abington /ID# 257164 Abington Pennsylvania 19001 —
Clinical Research of Philadelphia, LLC /ID# 257197 Philadelphia Pennsylvania 19114 —
Partners In Clinical Research /ID# 257855 Cumberland Rhode Island 02864 —
Premier Neurology /ID# 260359 Greenville South Carolina 29605 —
Coastal Carolina Research Center - North Charleston /ID# 257227 North Charleston South Carolina 29405 —
WR-ClinSearch /ID# 257160 Chattanooga Tennessee 37421-1605 —
KCA Neurology /ID# 274495 Franklin Tennessee 37067 —
Alliance for Multispecialty Research - Knoxville /ID# 257846 Knoxville Tennessee 37920 —
FutureSearch Trials of Neurology /ID# 257186 Austin Texas 78731 —
FutureSearch Trials of Dallas, LP /ID# 257142 Dallas Texas 75231 —
Elevate Clinical - Seabrook /ID# 274679 Houston Texas 77058 —
Houston Clinical Research Associates /ID# 272077 Houston Texas 77090 —
Red Star Research, LLC /ID# 257871 Lake Jackson Texas 77566 —
Radiance Clinical Research /ID# 271727 Lampasas Texas 76550 —
Epic Clinical Research - Lewisville /ID# 274480 Lewisville Texas 75057 —
Sms Clinical Research /ID# 278443 Mesquite Texas 75149 —
Clinpoint Trials /ID# 274524 Waxahachie Texas 75165 —
Foothill Family Draper Clinic /ID# 277876 Draper Utah 84020 —
Advanced Research Institute /ID# 257853 Ogden Utah 84405 —
J. Lewis Research - Salt Lake City - Foothill Drive /ID# 277877 Salt Lake City Utah 84109 —
J. Lewis Research, Inc. / Foothill Family Clinic South /ID# 258305 Salt Lake City Utah 84121-6923 —
Highland Clinical Research /ID# 257137 Salt Lake City Utah 84124 —
Charlottesville Medical Research /ID# 257154 Charlottesville Virginia 22911 —
Alliance for Multispecialty Research - Clinical Research Associates /ID# 257851 Norfolk Virginia 23502 —
Northwest Clinical Research Center /ID# 257381 Bellevue Washington 98007 —
Puget Sound Neurology /ID# 257174 Tacoma Washington 25328 —
Vaught Neurological Services /ID# 267519 Beckley West Virginia 25801 —
West Virginia Univ School Med /ID# 258898 Morgantown West Virginia 26506 —
Mind+ Neurology /ID# 274486 Mequon Wisconsin 53092 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06417775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06417775 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →